Fig. 2 | Scientific Reports

Fig. 2

From: Safety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug discovery

Fig. 2

CRP concentration in plasma of the pigs receiving NaCl (control group, black bars), pigs receiving ASC (white bars), pigs receiving WJ-MSC (grey bars) in a four timepoints of the experiment: O: pre-1st cells/NaCl administration, I: post-1st cells/NaCl administration, II: post-2st cells/NaCl administration, III: one week after NTs administration. Data are presented as mean ± SD (n = 3 per group). Due to the small sample size, individual data points are not displayed. The statistical analysis was determined by a two-way ANOVA followed by Tukey’smultiple comparison test (p < 0.05). Asterisks indicate differences in the CRP concentration between examining timepoints (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Back to article page